Convenience stores boost Dor Alon Israel profits

Nine-month net profit rose 12.8% to NIS 29.6m. and revenues increased 54.3% to NIS 5.63b.

November 24, 2005 08:27


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Dor Alon Energy Israel had a 26.3% rise in net income for the third quarter of 2005 resulting from expanding its chain of convenient stores connected to its gas stations, the company said Wednesday. The Israeli energy subsidiary of the Alon Oil Group said that net profit rose to NIS 10.1m. for the three months ending September 30, while profits jumped 55.9% to NIS 2.14b. Dor Alon Israel CEO Israel Yaniv said that the company's decision to focus on expanding its convenience stores on the premises of the Dor Alon gas stations had proved to be successful. Yaniv also attributed the success of the company so far this year to the completion of its restructuring process. Nine-month net profit rose 12.8% to NIS 29.6m. and revenues increased 54.3% to NIS 5.63b.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection